Furthermore, miR-125b overexpression was shown to accelerate the oncogenicity of the BCR-ABL1 fusion protein, a hallmark of chronic myeloid leukaemia (CML) but one also observed in a subset of paediatric ALL [52]. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.